Empresa Icosavax, Inc.
Acciones
ICVX
US45114M1099
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 60
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Thomas Russo
DFI | Director of Finance/CFO | 52 | 01/06/21 |
Jennifer Raymond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 64 | 01/09/18 | |
Douglas Holtzman
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/08/19 |
Lori Stewart
HRO | Human Resources Officer | - | - |
Cassia Cearley
PRN | Corporate Officer/Principal | 42 | 01/12/19 |
Ami Shah Brown
LAW | General Counsel | - | - |
General Counsel | 54 | 10/09/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 50 090 341 | 48 755 518 ( 97,34 %) | 0 | 97,34 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+0,17 % | 42,86 mil M | |
+10,92 % | 42,74 mil M | |
+44,30 % | 41,36 mil M | |
-6,20 % | 27,68 mil M | |
+5,23 % | 25,15 mil M | |
-24,79 % | 18,63 mil M | |
+26,69 % | 12,37 mil M | |
-3,13 % | 11,92 mil M | |
+6,57 % | 11,21 mil M |